‏1,152.00 ₪

The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment

‏1,152.00 ₪
ISBN13
9781615372218
מהדורה
6
עמודים / Pages
912
תאריך יציאה לאור
16 במרץ 2021

Under the direction of a new lead editor and team, the Sixth Edition of The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment has been completely revised and restructured and represents the cutting edge of research, practice, and policy in substance use disorder (SUD) treatment. A one-stop reference for evidence-based information on neurobiology, assessment, treatment, and research trends in SUDs, the book is an indispensable resource for trainees and veteran clinicians alike. Noteworthy additions are the new and substantive sections on public health issues and comorbidities, the expanded coverage of cannabis (encompassing neurobiology, the latest treatment approaches and harm-reduction strategies, and cannabis policy and public health perspectives), and the new chapters on digitally delivered therapies and behavioral addictive disorders (e.g., gambling disorder, compulsive internet use). As a complement to the contributions of distinguished luminaries in the field, dozens of new contributors have been added to the roster, for fresh and diverse viewpoints on topics old and new. The end result is a volume that is dynamic, comprehensive, and sure to become a classic.

The most authoritative reference for clinicians and researchers in the field of addiction and an excellent manual for residents in psychiatry, general medicine, and allied fields, The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment will engage, enlighten, and inform.

מידע נוסף
מהדורה 6
עמודים / Pages 912
תאריך יציאה לאור 16 במרץ 2021
תוכן עניינים
  • Part I: The Basis of Substance-Related and Addictive Disorders

  • Chapter 1. Neurocircuitry of Addiction
  • Chapter 2. Genetics and Epigenetics of Addiction
  • Chapter 3. Epidemiology of Addiction
  • Chapter 4. Substance Use Disorder Diagnoses in DSM-5
  • Part II: Assessment and Treatment

  • Chapter 5. Assessment
  • Chapter 6. Screening and Brief Intervention
  • Chapter 7. Treating Addiction Like a Chronic Illness: A Practical Clinical Model
  • Part III: Specific Drugs of Abuse: Neurobiology and Pharmacotherapy

  • Chapter 8. Neurobiology of Alcohol
  • Chapter 9. Treatment of Alcohol-Related Disorders
  • Chapter 10. Neurobiology of Stimulants
  • Chapter 11. Treatment of Stimulant-Related Disorders
  • Chapter 12. Neurobiology of Opioids
  • Chapter 13. Methadone and Buprenorphine Maintenance Treatment of Opioid-Related Disorders
  • Chapter 14. Opioid Antagonist Treatment of Opioid-Related Disorders
  • Chapter 15. Neurobiology and Treatment of Hallucinogen Use Disorder
  • Chapter 16. Neurobiology of Marijuana
  • Chapter 17. Treatment of Cannabis-Related Disorders
  • Chapter 18. Neurobiology of Nicotine and Tobacco
  • Chapter 19. Treatment of Tobacco-Related Disorders
  • Chapter 20. Neurobiology and Treatment of Sedative-, Hypnotic-, and Anxiolytic-Related Disorders
  • Chapter 21. Neurobiology and Treatment of Anabolic-Androgenic Steroid–Related Disorders
  • Part IV: Nonpharmacotherapeutic Treatment Modalities

  • Chapter 22. Psychodynamic Psychotherapy
  • Chapter 23. Cognitive-Behavioral Therapy
  • Chapter 24. Contingency Management
  • Chapter 25. Motivational Enhancement
  • Chapter 26. Alcoholics Anonymous and Twelve-Step Facilitation
  • Chapter 27. Family Therapy
  • Chapter 28. Network Therapy
  • Chapter 29. Digitally Delivered Therapies
  • Chapter 30. Mindfulness, Exercise, and Other Alternative Approaches
  • Part V: Public Health Issues

  • Chapter 31. The U.S. Opioid Crisis
  • Chapter 32. Cannabis Policy and Use
  • Chapter 33. HIV/AIDS and Hepatitis C
  • Chapter 34. Public Health and Nicotine
  • Chapter 35. Prevention of Substance Use Disorders
  • Part VI: Special Populations

  • Chapter 36. Substance-Related Disorders in Women
  • Chapter 37. Substance-Related Disorders in Adolescents
  • Chapter 38. Substance-Related Disorders in Patients With Chronic Pain
  • Chapter 39. Substance Use and Related Disorders in Sexual and Gender Minority Populations
  • Chapter 40. Cross-Cultural Aspects of Substance-Related and Addictive Disorders
  • Chapter 41. Substance-Related Disorders in Older Adults
  • Chapter 42. Behavioral Addictive Disorders
  • Part VII: Psychiatric Comorbidity in Substance-Related Disorders

  • Chapter 43. Epidemiology of Co-Occurring Psychiatric and Substance Use Disorders
  • Chapter 44. Mood Disorders
  • Chapter 45. Anxiety Disorders
  • Chapter 46. Eating Disorders
  • Chapter 47. Attention-Deficit/Hyperactivity Disorder
  • Chapter 48. Trauma- and Stressor-Related Disorders
  • Chapter 49. Schizophrenia Spectrum and Other Psychotic Disorders
  • Part VIII: Special Topics

  • Chapter 50. Testing for Substances of Abuse
  • Chapter 51. Forensic Addiction Psychiatry
  • Chapter 52. Medical Education on Addiction
  • Chapter 53. Addiction in the Workplace
  • Index